These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7955188)

  • 21. Effects of pacing rate and timing of defibrillation shock on the relation between the defibrillation threshold and the upper limit of vulnerability in open chest dogs.
    Chen PS; Feld GK; Mower MM; Peters BB
    J Am Coll Cardiol; 1991 Nov; 18(6):1555-63. PubMed ID: 1939961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
    Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA
    Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative reproducibility of defibrillation threshold and upper limit of vulnerability.
    Swerdlow CD; Davie S; Ahern T; Chen PS
    Pacing Clin Electrophysiol; 1996 Dec; 19(12 Pt 1):2103-11. PubMed ID: 8994950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol.
    Lemke B; Lawo T; Zarse M; Lubinski A; Kreutzer U; Mueller J; Schuchert A; Mitzenheim S; Danilovic D; Deneke T;
    Europace; 2008 Aug; 10(8):907-13. PubMed ID: 18515789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate reproducibility of upper limit of vulnerability measurements in patients undergoing transvenous implantable cardioverter defibrillator implantation.
    Ellenbogen KA; Wood MA; Gilligan DM; Crofts T; London W; McClish D
    J Cardiovasc Electrophysiol; 1998 Jun; 9(6):588-95. PubMed ID: 9654223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Truncated biphasic pulses for transthoracic defibrillation.
    Bardy GH; Gliner BE; Kudenchuk PJ; Poole JE; Dolack GL; Jones GK; Anderson J; Troutman C; Johnson G
    Circulation; 1995 Mar; 91(6):1768-74. PubMed ID: 7882486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of the upper limit of vulnerability during defibrillator implantation can substitute defibrillation threshold measurement.
    Bessho R; Tanaka S
    Int J Artif Organs; 1998 Mar; 21(3):151-60. PubMed ID: 9622114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantation of cardioverter defibrillators without induction of ventricular fibrillation.
    Swerdlow CD
    Circulation; 2001 May; 103(17):2159-64. PubMed ID: 11331256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of simultaneous versus sequential defibrillation pulsing techniques using a nonthoracotomy system.
    Hsia HH; Kleiman RB; Flores BT; Marchlinski FE
    Pacing Clin Electrophysiol; 1994 Jul; 17(7):1222-30. PubMed ID: 7937228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment.
    Kühlkamp V; Mewis C; Suchalla R; Mermi J; Dörnberger V; Seipel L
    Int J Cardiol; 1999 Jun; 69(3):271-9. PubMed ID: 10402110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lidocaine on relation between defibrillation threshold and upper limit of vulnerability in open-chest dogs.
    Topham SL; Cha YM; Peters BB; Chen PS
    Circulation; 1992 Mar; 85(3):1146-51. PubMed ID: 1537112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators.
    Hou CJ; Chang-Sing P; Flynn E; Martinez L; Peterson J; Ottoboni LK; Liem LB; Sung RJ
    Circulation; 1995 Nov; 92(9):2558-64. PubMed ID: 7586357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of defibrillation. Critical points and the upper limit of vulnerability.
    Walcott GP; Walcott KT; Ideker RE
    J Electrocardiol; 1995; 28 Suppl():1-6. PubMed ID: 8656095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardioverter-defibrillator implantations without thoracotomy: clinical experience with various electrode configurations and defibrillation wave forms of an endocardial/subcutaneous defibrillator system].
    Neuzner J; Huth C; Friedl A; Reinisch P; Pitschner HF; Schlepper M
    Z Kardiol; 1993 Feb; 82(2):99-107. PubMed ID: 8465572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical mapping of ventricular defibrillation in isolated swine right ventricles: demonstration of a postshock isoelectric window after near-threshold defibrillation shocks.
    Wang NC; Lee MH; Ohara T; Okuyama Y; Fishbein GA; Lin SF; Karagueuzian HS; Chen PS
    Circulation; 2001 Jul; 104(2):227-33. PubMed ID: 11447091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length.
    Zima E; Gergely M; Soós P; Gellér LA; Nemes A; Acsády G; Merkely B
    J Cardiovasc Electrophysiol; 2006 Apr; 17(4):377-81. PubMed ID: 16643358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of defibrillation efficacy in patients undergoing epicardial defibrillator implantation. The Multicenter Pacemaker-Cardioverter-Defibrillator (PCD) Investigators Group.
    Leitch JW; Yee R
    J Am Coll Cardiol; 1993 Jun; 21(7):1632-7. PubMed ID: 8496530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ventricular shock strength on cardiac hemodynamics.
    Tokano T; Bach D; Chang J; Davis J; Souza JJ; Zivin A; Knight BP; Goyal R; Man KC; Morady F; Strickberger SA
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8):791-7. PubMed ID: 9727657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mechanism of induction and termination of ventricular fibrillation--significance of dispersion of ventricular repolarization].
    Behrens S; Zabel M; Franz MR; Schultheiss HP
    Z Kardiol; 2000 Dec; 89(12):1098-107. PubMed ID: 11201025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system.
    Souza JJ; Malkin RA; Ideker RE
    Circulation; 1995 Feb; 91(4):1247-52. PubMed ID: 7850965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.